← Back to Search

Communication Skills Training for Cancer Care in the Elderly

N/A

Waitlist Available

Led By Smita Banerjee, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient Eligibility: MSK patients 65 years of age and over as per EMR

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial is testing a new method to help doctors communicate better with elderly patients and their caregivers.

Who is the study for?

This trial is for English-speaking oncology clinicians who see patients aged 65 and over, including attendings, fellows, NPs or PAs in GI, GU Oncology, Lymphoma, Bone Marrow Transplant or Geriatrics. It's also for their patients of the same age range and caregivers if the patient had a new visit within the last 6 months.Check my eligibility

What is being tested?

The study tests a training program aimed at improving how doctors talk to older cancer patients and their caregivers. Clinicians' skills are assessed using various tools like self-efficacy assessments and empathy questionnaires before and after training.See study design

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects. However, participants may experience changes in communication practices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older, according to my medical records.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of Health Care Provider (HCP) training

Participants satisfaction with Health Care Provider (HCP) training

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: GI/GU/Lymphoma OncologistsExperimental Treatment3 Interventions

Doctors specializing in treating gastrointestinal cancer (cancer of the stomach, pancreas, colon, etc.), genitourinary cancer (cancer of the genitals and urinary tract), and lymphoma (cancer affecting the blood and lymph nodes)

Group II: Participants with GI/GU/Lymphoma CancerActive Control3 Interventions

Patients of the physicians in group 1

Group III: Caregivers of Participants with GI/GU/Lymphoma CancerActive Control2 Interventions

Family members or caregivers of the patients in group 2

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Self-Efficacy Assessment

2018

N/A

~90

UCLA Geriatrics Attitudes Scale

2018

N/A

~90

Course Evaluations

2018

N/A

~90

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,534 Total Patients Enrolled

Smita Banerjee, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

4 Previous Clinical Trials

1,365 Total Patients Enrolled

Media Library

UCLA Geriatrics Attitudes Scale Clinical Trial Eligibility Overview. Trial Name: NCT03530969 — N/A

Gastrointestinal Cancer Research Study Groups: GI/GU/Lymphoma Oncologists, Participants with GI/GU/Lymphoma Cancer, Caregivers of Participants with GI/GU/Lymphoma Cancer

Gastrointestinal Cancer Clinical Trial 2023: UCLA Geriatrics Attitudes Scale Highlights & Side Effects. Trial Name: NCT03530969 — N/A

UCLA Geriatrics Attitudes Scale 2023 Treatment Timeline for Medical Study. Trial Name: NCT03530969 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research currently enrolling participants?

"The medical trial listed on clinicaltrials.gov, which was first released on May 7th 2018 and last amended on March 16th 2022, is not presently enrolling patients. However, there are 1,729 other studies that are currently accepting participants into their trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Geriatric Communication Skills Training Program for Oncology Clinicians

2018. "Geriatric Communication Skills Training Program for Oncology Clinicians". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03530969.